Tetrahydrofuran → 2-(4-Hydroxy-2,2,6,6-tetramethyl-piperidin-1-yl)-1,3-di-p-tolyl-isourea
反応式
[CH3:1][C:2]1([CH3:12])[N:7]([O])[C:6]([CH3:10])([CH3:9])[CH2:5][CH:4]([OH:11])[CH2:3]1.[H][H].[C:15]1([CH3:31])[CH:20]=[CH:19][C:18]([N:21]=[C:22]=[N:23][C:24]2[CH:29]=[CH:28][C:27]([CH3:30])=[CH:26][CH:25]=2)=[CH:17][CH:16]=1.C1C[O:35]CC1>>[OH:11][CH:4]1[CH2:3][C:2]([CH3:12])([CH3:1])[N:7]([O:35][C:22](=[N:23][C:24]2[CH:25]=[CH:26][C:27]([CH3:30])=[CH:28][CH:29]=2)[NH:21][C:18]2[CH:19]=[CH:20][C:15]([CH3:31])=[CH:16][CH:17]=2)[C:6]([CH3:10])([CH3:9])[CH2:5]1参加物
5
実験手順
4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (1.9 g, 11 mmol) is dissolved in THF (40 ml) and hydrogenated in the presence of 0.035 g Pt (5% on carbon) catalyst using 4 bar hydrogen pressure. The hydrogen uptake stops after approximately one hour. The reaction mixture is then filtered and mixed with the solution of bis-p-tolyl-carbodiimide (2.45 g, 11 mmol) in THF (30 ml). The solution is stirred under argon at room temperature for 16 hours and concentrated. The residue is chromatographed on silica gel with hexane-ethyl acetate (1:1) and the pure fractions are crystallized from ethyl acetate to afford 1.6 g of the title compound as a colorless solid, mp. 124-126° C.
後処理
- filtrationThe reaction mixture is then filtered
- concentrationconcentrated
- customThe residue is chromatographed on silica gel with hexane-ethyl acetate (1:1)
- customthe pure fractions are crystallized from ethyl acetate
出典と根拠
- ORDレコード
- ord-4fe92e9146c04b1e88aafceca9fb7863
- 出典データセット
- uspto-grants-2014_03
- 特許番号
- US08669398B2
反応ノート
読み込み中…